1 |
VAN DIJK S P J, COERTS H I, LONCAR I, et al. Deescalating follow-up after hemithyroidectomy for patients with low-risk papillary thyroid microcarcinoma[J]. JAMA Otolaryngol Head Neck Surg, 2023, 149(1): 42-48.
|
2 |
SUGITANI I. Active surveillance of low-risk papillary thyroid microcarcinoma[J]. Best Pract Res Clin Endocrinol Metab, 2023, 37(1): 101630.
|
3 |
WALGAMA E, SACKS W L, HO A S. Papillary thyroid microcarcinoma: optimal management versus overtreatment[J]. Curr Opin Oncol, 2020, 32(1): 1-6.
|
4 |
LIU Z M, WANG L Q, YI P F, et al. Risk factors for central lymph node metastasis of patients with papillary thyroid microcarcinoma: a meta-analysis[J]. Int J Clin Exp Pathol, 2014, 7(3): 932-937.
|
5 |
SASAKI T, MIYAUCHI A, FUJISHIMA M, et al. Comparison of postoperative unfavorable events in patients with low-risk papillary thyroid carcinoma: immediate surgery versus conversion surgery following active surveillance[J]. Thyroid, 2023, 33(2): 186-191.
|
6 |
SUGITANI I, ITO Y, TAKEUCHI D, et al. Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan association of endocrine surgery task force on management for papillary thyroid microcarcinoma[J]. Thyroid, 2021, 31(2): 183-192.
|
7 |
ITO Y, URUNO T, NAKANO K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid[J]. Thyroid, 2003, 13(4): 381-387.
|
8 |
SUGITANI I, FUJIMOTO Y. Symptomatic versus asymptomatic papillary thyroid microcarcinoma:a retrospective analysis of surgical outcome and prognostic factors[J]. Endocr J, 1999, 46(1): 209-216.
|
9 |
HAUGEN B R, ALEXANDER E K, BIBLE K C,et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.
|
10 |
ZHAO H Q, LI H H. Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases[J]. Eur J Radiol, 2019, 112: 14-21.
|
11 |
ZHANG L, WEI W J, JI Q H, et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients[J]. J Clin Endocrinol Metab, 2012, 97(4): 1250-1257.
|
12 |
SIDDIQUI S, WHITE M G, ANTIC T, et al. Clinical and pathologic predictors of lymph node metastasis and recurrence in papillary thyroid microcarcinoma[J]. Thyroid, 2016, 26(6): 807-815.
|
13 |
LEE J, SONG Y, SOH E Y. Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma[J]. J Korean Med Sci, 2014, 29(1): 48-52.
|
14 |
SEITIDIS G, NIKOLAKOPOULOS S, HENNESSY E A, et al. Network meta-analysis techniques for synthesizing prevention science evidence[J]. Prev Sci, 2022, 23(3): 415-424.
|
15 |
PAGE M J, MCKENZIE J E, BOSSUYT P M, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews[J]. J Clin Epidemiol, 2021, 134: 178-189.
|
16 |
ROSS D S, LITOFSKY D, AIN K B, et al. Recurrence after treatment of micropapillary thyroid cancer[J]. Thyroid, 2009, 19(10): 1043-1048.
|
17 |
GIORDANO D, GRADONI P, ORETTI G, et al. Treatment and prognostic factors of papillary thyroid microcarcinoma[J].Clin Otolaryngol,2010,35(2):118-124.
|
18 |
LOMBARDI C P, BELLANTONE R, CREA C D,et al.Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area[J]. World J Surg, 2010, 34(6): 1214-1221.
|
19 |
MERCANTE G, FRASOLDATI A, PEDRONI C,et al.Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients[J]. Thyroid, 2009, 19(7): 707-716.
|
20 |
KIM K J, KIM S M, LEE Y S, et al. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2, 309 consecutive patients[J]. Ann Surg Oncol, 2015, 22(1): 125-131.
|
21 |
CALISKAN M, PARK J H, JEONG J S, et al. Role of prophylactic ipsilateral central compartment lymph node dissection in papillary thyroid microcarcinoma[J]. Endocr J, 2012, 59(4): 305-311.
|
22 |
CHOW S M, LAW S C, CHAN J K, et al. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality[J]. Cancer, 2003, 98(1): 31-40.
|
23 |
CREACH K M, SIEGEL B A, NUSSENBAUM B, et al. Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma[J]. ISRN Endocrinol, 2012, 2012: 816386.
|
24 |
BESIC N, PILKO G, PETRIC R, et al. Papillary thyroid microcarcinoma: prognostic factors and treatment[J]. J Surg Oncol, 2008, 97(3): 221-225.
|
25 |
LEE C R, SON H, LEE S, et al. Lobectomy and prophylactic central neck dissection for papillary thyroid microcarcinoma: do involved lymph nodes mandate completion thyroidectomy?[J].World J Surg,2014,38(4): 872-877.
|
26 |
GAO R, JIA X, LIANG Y Q, et al. Papillary thyroid micro carcinoma: the incidence of high-risk features and its prognostic implications[J]. Front Endocrinol, 2019, 10: 74.
|
27 |
CHO J K, KIM J Y, JEONG C Y, et al. Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age[J]. J Korean Surg Soc, 2012, 82(5): 281-287.
|
28 |
VARGAS-PINTO S, ROMERO ARENAS M A. Lobectomy compared to total thyroidectomy for low-risk papillary thyroid cancer: a systematic review[J]. J Surg Res, 2019, 242: 244-251.
|
29 |
ZHAO H Q, CUI L.Extent of surgery and the prognosis of unilateral papillary thyroid microcarcinoma[J]. Front Endocrinol, 2021, 12: 655608.
|
30 |
KOOT A, SOARES P, ROBENSHTOK E, et al. Position paper from the Endocrine Task Force of the European Organisation for Research and Treatment of Cancer (EORTC) on the management and shared decision making in patients with low-risk micro papillary thyroid carcinoma[J]. Eur J Cancer, 2023, 179: 98-112.
|
31 |
HARTL D M, MAMELLE E, BORGET I, et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma[J]. World J Surg, 2013, 37(8): 1951-1958.
|
32 |
GUO K, WANG Z Y. Risk factors influencing the recurrence of papillary thyroid carcinoma: a systematic review and meta-analysis[J]. Int J Clin Exp Pathol, 2014, 7(9): 5393-5403.
|
33 |
YIN X J, LIU C P, GUO Y W, et al. Influence of tumor extent on central lymph node metastasis in solitary papillary thyroid microcarcinomas: a retrospective study of 1092 patients[J].World J Surg Oncol,2017,15(1):133.
|
34 |
WADA N, DUH Q Y, SUGINO K, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection[J]. Ann Surg, 2003, 237(3): 399-407.
|
35 |
ZHENG X Q, PENG C, GAO M, et al. Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1, 587 patients[J]. Cancer Biol Med, 2019, 16(1): 121-130.
|
36 |
ZHAO Q Z, MING J, LIU C P, et al. Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma[J]. Ann Surg Oncol, 2013, 20(3): 746-752.
|
37 |
CALÒ P G, PISANO G, MEDAS F, et al. Total thyroidectomy without prophylactic central neck dissection in clinically node-negative papillary thyroid cancer: is it an adequate treatment?[J]. World J Surg Oncol, 2014, 12: 152.
|
38 |
SHAN C X, ZHANG W, JIANG D Z, et al. Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis[J]. Laryngoscope, 2012, 122(4): 797-804.
|
39 |
XUE S, WANG P S, LIU J, et al. Prophylactic central lymph node dissection in cN0 patients with papillary thyroid carcinoma: a retrospective study in China[J]. Asian J Surg, 2016, 39(3): 131-136.
|
40 |
SO Y K, SEO M Y, SON Y I. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications[J]. Surgery, 2012, 151(2): 192-198.
|